down arrow

MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
540.00
-11 (-2.0%)

Dec 04

OME

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Getinge AB
BONESUPPORT HOLDING AB
CellaVision AB
Surgical Science Sweden AB
Vitrolife AB
Biotage AB
MedCap AB
Elekta AB
Genovis AB
Bactiguard Holding AB
Xvivo Perfusion AB
Why is MedCap AB ?
1
Flat results in Jun 25
  • ROCE(HY) Lowest at 15.86%
  • INTEREST(Q) Highest at SEK 6.9 MM
2
With ROE of 15.26%, it has a very expensive valuation with a 6.21 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -4.12%, its profits have fallen by -3.4%
3
Underperformed the market in the last 1 year
  • Even though the market (OMX Stockholm 30) has generated returns of 9.24% in the last 1 year, the stock has hugely underperformed and has generate negative returns of -4.12% returns
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MedCap AB for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
MedCap AB
-2.88%
-0.08
48.71%
OMX Stockholm 30
8.01%
0.51
18.11%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
19.96%
EBIT Growth (5y)
29.85%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.30
Tax Ratio
20.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.53%
ROE (avg)
14.67%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
6.21
EV to EBIT
32.36
EV to EBITDA
21.60
EV to Capital Employed
7.31
EV to Sales
4.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.60%
ROE (Latest)
15.26%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 326 MM

RAW MATERIAL COST(Y)

Fallen by -5.37% (YoY

CASH AND EQV(HY)

Highest at SEK 650.3 MM

NET SALES(Q)

Highest at SEK 521.7 MM

OPERATING PROFIT(Q)

Highest at SEK 113 MM

OPERATING PROFIT MARGIN(Q)

Highest at 21.66 %

PRE-TAX PROFIT(Q)

Highest at SEK 74.4 MM

-6What is not working for the Company
ROCE(HY)

Lowest at 15.86%

INTEREST(Q)

Highest at SEK 6.9 MM

Here's what is working for MedCap AB
Operating Cash Flow
Highest at SEK 326 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Sales
Highest at SEK 521.7 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit
Highest at SEK 113 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at 21.66 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK 74.4 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Cash and Eqv
Highest at SEK 650.3 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -5.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at SEK 34.1 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for MedCap AB
Interest
At SEK 6.9 MM has Grown at 50%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Interest
Highest at SEK 6.9 MM
in the last five periods and Increased by 50% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."